Furthermore, by determining the quantitative expression of the HERC1 gene in a panel of myeloid related disorders we found a steep decline in those samples collected from patients with newly diagnosed AML, CML and PMF (Figure 1). This evidence concerns the gene HERC1 and chronic myelogenous leukemia, BCR-ABL1 positive.